Insulet Corp. (PODD)
145.29
-7.19
(-4.72%)
USD |
NASDAQ |
Nov 16, 16:00
145.37
+0.08
(+0.06%)
After-Hours: 20:00
Insulet Price : 145.29 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 153.50 | 155.39 | 144.88 | 145.29 | 1.975M |
| Nov 13, 2026 | 150.47 | 153.79 | 145.31 | 152.48 | 1.591M |
| Nov 12, 2026 | 150.42 | 151.60 | 148.80 | 149.29 | 745765.0 |
| Nov 11, 2026 | 146.20 | 150.35 | 146.15 | 150.03 | 1.043M |
| Nov 10, 2026 | 148.72 | 149.26 | 145.94 | 148.06 | 1.077M |
| Nov 09, 2026 | 146.85 | 150.52 | 145.41 | 149.81 | 1.332M |
| Nov 06, 2026 | 155.60 | 155.60 | 143.28 | 146.51 | 1.568M |
| Nov 05, 2026 | 167.33 | 168.47 | 152.23 | 156.12 | 1.319M |
| Nov 04, 2026 | 148.61 | 165.46 | 148.55 | 165.02 | 2.604M |
| Nov 03, 2026 | 152.08 | 156.98 | 151.15 | 154.86 | 1.620M |
| Nov 02, 2026 | 150.22 | 154.70 | 149.68 | 153.61 | 1.773M |
| Oct 30, 2026 | 154.60 | 154.95 | 149.48 | 149.68 | 1.090M |
| Oct 29, 2026 | 150.54 | 152.66 | 150.54 | 152.50 | 1.297M |
| Oct 28, 2026 | 149.28 | 150.56 | 146.62 | 148.93 | 1.035M |
| Oct 27, 2026 | 148.07 | 150.65 | 146.84 | 149.83 | 943833.0 |
| Oct 26, 2026 | 149.01 | 150.74 | 146.71 | 149.26 | 1.526M |
| Oct 23, 2026 | 147.87 | 149.69 | 145.00 | 149.01 | 803142.0 |
| Oct 22, 2026 | 142.47 | 148.35 | 142.47 | 148.12 | 1.214M |
| Oct 21, 2026 | 141.59 | 146.63 | 140.81 | 141.90 | 1.046M |
| Oct 20, 2026 | 143.78 | 145.00 | 141.82 | 142.64 | 1.137M |
| Oct 19, 2026 | 140.78 | 142.37 | 139.46 | 141.96 | 2.306M |
| Oct 16, 2026 | 140.46 | 143.31 | 140.22 | 141.10 | 1.618M |
| Oct 15, 2026 | 136.51 | 139.69 | 136.02 | 138.77 | 1.658M |
| Oct 14, 2026 | 139.72 | 139.74 | 133.58 | 133.93 | 2.318M |
| Oct 13, 2026 | 140.79 | 141.86 | 137.12 | 138.13 | 1.347M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Boston Scientific Corp. | 43.69 |
| Abbott Laboratories | 107.45 |
| TransMedics Group, Inc. | 92.21 |
| The Cooper Cos., Inc. | 61.88 |
| Stryker Corp. | 310.72 |
Price Related Metrics
| PE Ratio | 24.90 |
| PS Ratio | 3.186 |
| PEG Ratio | 0.3593 |
| Price to Book Value | 6.382 |
| Price to Free Cash Flow | 43.69 |
| Earnings Yield | 4.02% |
| Market Cap | 10.08B |
| PEGY Ratio | 0.3593 |
| Operating PE Ratio | 17.30 |
| Normalized PE Ratio | 24.91 |